Loading...

The Impact of Pharma Mergers on CROs

10 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 13, 2017

BioAgilytix Global CSO, Afshin Safavi, discusses how mergers and acquisitions have impacted CROs and drug development as part of the "Business of Bioanalysis" panel hosted by Bioanalysis Zone.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...